Pharmakologisches Studienzentrum Chemnitz GmbH
About Pharmakologisches Studienzentrum Chemnitz GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
4
Hoffmann-La Roche
3
Boehringer Ingelheim
2
Emalex Biosciences Inc.
2
Institut de Recherches Internationales Servier
1
Janssen-Cilag International NV
1
Janssen-Cilag Ltd.
1
Perception Neuroscience
1
Pfizer
1
Theranexus
1
Clinical Trials at Pharmakologisches Studienzentrum Chemnitz GmbH
During the past decade, Pharmakologisches Studienzentrum Chemnitz GmbH conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2005-12-01
2007-06-01
Completed
418
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2006-08-01
2008-04-01
Completed
214
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
2010-11-30
2020-09-10
Completed
799
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
2011-05-01
2012-05-01
Completed
990
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
2014-03-27
2021-04-16
Completed
389
Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms
2015-02-01
2017-09-01
Completed
500
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Pharmakologisches Studienzentrum Chemnitz GmbH" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Emalex Biosciences Inc." with 2 trials sponsored and "Institut de Recherches Internationales Servier"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Pharmakologisches Studienzentrum Chemnitz GmbH"
#1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator and "Precision For Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Pharmakologisches Studienzentrum Chemnitz GmbH
According to Clinical.Site data, the most researched conditions in "Pharmakologisches Studienzentrum Chemnitz GmbH" are
"Alzheimer's Disease" (4 trials), "Dyslipidemia" (4 trials), "Depressive Disorder, Major" (2 trials), "Type II Diabetes Mellitus" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Pharmakologisches Studienzentrum Chemnitz GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Pharmakologisches Studienzentrum Chemnitz GmbH
Most popular intervention types in "Pharmakologisches Studienzentrum Chemnitz GmbH" are "Drug" (17 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Pitavastatin" (4 trials), "Atorvastatin" (3 trials), "Ecopipam" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Pharmakologisches Studienzentrum Chemnitz GmbH
The vast majority of trials in "Pharmakologisches Studienzentrum Chemnitz GmbH" are
17 trials for "All" genders.
Clinical Trials Status at Pharmakologisches Studienzentrum Chemnitz GmbH
Currently, there are NaN active trials in "Pharmakologisches Studienzentrum Chemnitz GmbH".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Pharmakologisches Studienzentrum Chemnitz GmbH,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Pharmakologisches Studienzentrum Chemnitz GmbH, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".